Financial reports
NT 10-Q
Notice of late quarterly filing
9 May 18
10-K/A
2017 FY
Annual report (amended)
30 Apr 18
10-K
2017 FY
Annual report
30 Mar 18
NT 10-K
Notice of late annual filing
15 Mar 18
10-Q
2017 Q3
Quarterly report
8 Nov 17
10-Q
2017 Q2
Quarterly report
4 Aug 17
10-Q
2017 Q1
Quarterly report
10 May 17
10-K
2016 FY
Annual report
16 Mar 17
10-Q
2016 Q3
Quarterly report
7 Nov 16
10-Q
2016 Q2
Quarterly report
9 Aug 16
Current reports
8-K
BioAmber Provides Update on Liquidation Process
26 Oct 18
8-K
BioAmber Provides Update on Liquidation ProcessĀ & Announces Resignations
4 Sep 18
8-K
BioAmber Provides Update on Liquidation Process
14 Aug 18
8-K
BioAmber Provides Update on Sales Process
1 Aug 18
8-K
BioAmber Receives Favourable Court Ruling and Approval for DIP Financing
20 Jun 18
8-K
BioAmber Announces Filing for Stay of Proceedings on Creditors
8 May 18
8-K
BioAmber Inc. Receives Notice of Delisting by TSX
16 Feb 18
8-K
BioAmber Inc. Receives Notice of Delisting Review by TSX
15 Feb 18
8-K
BioAmber Inc. Announces Registered Direct Offering; Termination of Underwriting Agreement for Previously-Announced Public Offering
13 Feb 18
8-K
Bioamber Inc. Announces Pricing of US$10 Million Underwritten Public Offering
8 Feb 18
Registration and prospectus
25-NSE
Exchange delisting
27 Feb 18
424B5
Prospectus supplement for primary offering
13 Feb 18
424B5
Prospectus supplement for primary offering
9 Feb 18
424B5
Prospectus supplement for primary offering
8 Feb 18
424B5
Prospectus supplement for primary offering
6 Feb 18
424B5
Prospectus supplement for primary offering
5 Feb 18
424B5
Prospectus supplement for primary offering
9 Aug 17
424B5
Prospectus supplement for primary offering
8 Aug 17
25-NSE
Exchange delisting
5 May 17
424B5
Prospectus supplement for primary offering
24 Jan 17
Proxies
DEFA14A
Additional proxy soliciting materials
16 Apr 18
DEF 14A
Definitive proxy
30 Mar 18
PRE 14A
Preliminary proxy
20 Mar 18
DEF 14A
Definitive proxy
31 Mar 17
DEFA14A
Additional proxy soliciting materials
31 Mar 17
DEF 14A
Definitive proxy
6 Apr 16
DEFA14A
Additional proxy soliciting materials
6 Apr 16
DEF 14A
Definitive proxy
2 Apr 15
DEFA14A
Additional proxy soliciting materials
2 Apr 15
DEF 14A
Definitive proxy
30 Apr 14
Other
UPLOAD
Letter from SEC
7 Feb 18
CORRESP
Correspondence with SEC
17 Jan 18
UPLOAD
Letter from SEC
28 Nov 17
CORRESP
Correspondence with SEC
27 Oct 17
UPLOAD
Letter from SEC
27 Sep 17
CT ORDER
Confidential treatment order
4 Apr 17
EFFECT
Notice of effectiveness
12 Jan 17
CT ORDER
Confidential treatment order
14 Sep 16
CT ORDER
Confidential treatment order
6 Apr 16
EFFECT
Notice of effectiveness
9 Jul 14
Ownership
SC 13G/A
BioAmber Inc.
8 Aug 19
SC 13G/A
BioAmber Inc.
8 Aug 19
SC 13G/A
BioAmber Inc.
25 Jul 19
SC 13G/A
BioAmber Inc.
19 Jul 19
SC 13G
BioAmber Inc.
10 Jul 19
SC 13G
BioAmber Inc.
9 Jul 19
SC 13D/A
BioAmber Inc.
14 Feb 19
SC 13G/A
BioAmber Inc.
8 Feb 19
SC 13G/A
BioAmber Inc.
3 Jan 19
SC 13G/A
BioAmber Inc.
7 Jun 18